(Q33339946)

25 July 2017

title

Predicting the liver histology in chronic hepatitis C: how good is the clinician? (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

Romagnuolo J

1

1 reference

25 July 2017

Jhangri GS

series ordinal

2

1 reference

25 July 2017

Jewell LD

series ordinal

3

1 reference

25 July 2017

Bain VG

series ordinal

4

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

The American Journal of Gastroenterology

25 July 2017

published in

1 reference

25 July 2017

volume

96

1 reference

25 July 2017

issue

11

1 reference

25 July 2017

page(s)

3165-3174

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Value of liver biopsy prior to interferon therapy for chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

A case of pseudolymphoma of the liver with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

Histopathology of chronic hepatitis C in relation to epidemiological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05275.X

10.1111/J.1572-0241.2001.05275.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference